Microsoft has made a significant step forward in developing artificial intelligence (AI) that can diagnose diseases with higher accuracy and lower costs than human doctors. The company’s new AI tool, called the MAI Diagnostic Orchestrator (MAI-DxO), uses a combination of leading AI models to analyze medical records and provide accurate diagnoses.
In a test using 304 case studies from the New England Journal of Medicine, MAI-DxO outperformed human doctors with an accuracy rate of 80%, compared to 20% for the doctors. The tool also reduced costs by 20% by selecting less expensive tests and procedures.
Microsoft’s researchers have developed a system that queries multiple AI models, including OpenAI’s GPT and Google’s Gemini, in a way that mimics human experts working together. This approach is seen as a key step towards achieving “medical superintelligence.”
While the results are promising, some experts caution that the findings should be treated with caution, particularly if the tool is used in real-world clinical settings. The next step would be to demonstrate the tool’s effectiveness in a clinical trial comparing its results with those of real doctors treating real patients.
The development of AI-powered diagnostic tools has the potential to transform the healthcare industry, reducing costs and improving patient outcomes. Microsoft’s achievement highlights the progress being made in this area and raises questions about the future of medical diagnosis and treatment.
Source: https://www.wired.com/story/microsoft-medical-superintelligence-diagnosis